Transfusion Strategy in Myocardial Infarction and Anemia.

The article focuses on questioning the interpretation of the primary results of a restrictive transfusion strategy in acute myocardial infarction patients by Carson et al., emphasizing the potential harms overlooked by null-hypothesis testing. Bayesian analyses, incorporating prior probabilities, indicate a high probability of harm from a restrictive transfusion strategy, ranging from 90.8 percent to 99.8 percent, challenging the notion that the trial's results are negative.